Invention Grant
- Patent Title: Antiviral compounds highly effective as HCV-NS5A inhibitor
- Patent Title (中): 抗病毒化合物作为HCV-NS5A抑制剂非常有效
-
Application No.: US14298188Application Date: 2014-06-06
-
Publication No.: US09334291B2Publication Date: 2016-05-10
- Inventor: Zheng-Yun James Zhan
- Applicant: Zheng-Yun James Zhan
- Applicant Address: CN Shanghai
- Assignee: AB PHARMA LTD.
- Current Assignee: AB PHARMA LTD.
- Current Assignee Address: CN Shanghai
- Agency: Oblon, McClelland, Maier & Neustadt, L.L.P.
- Priority: CN201310224756 20130606
- Main IPC: C07D403/14
- IPC: C07D403/14 ; C07D409/14 ; C07D401/14 ; A61K45/06 ; C07D519/00 ; C07D491/056 ; C07D498/06 ; C07D491/113
Abstract:
Provided are compounds antiviral compounds represented by formula Ia and Ib: that are highly potent as HCV NS5A inhibitors, where the structural variables are as defined herein. These compounds are useful in, for example, inhibiting Hepatitis C virus and treating Hepatitis C virus infections.
Public/Granted literature
- US20140364429A1 ANTIVIRAL COMPOUNDS HIGHLY EFFECTIVE AS HCV-NS5A INHIBITOR Public/Granted day:2014-12-11
Information query
